A natural ent‑kaurane diterpenoid induces antiproliferation in ovarian cancer cells via ERK1/2 regulation and inhibition of cellular migration and invasion

Lee,Jin  Sun; Lee,Myung  Sun; Cha,Eun  Young; Thuong,Phuong  Thien; Sul,Ji  Young; Park,Jun  Beom; Ko,Young  Bok

doi:10.3892/mmr.2018.9377

A natural ent‑kaurane diterpenoid induces antiproliferation in ovarian cancer cells via ERK1/2 regulation and inhibition of cellular migration and invasion

Authors:
- Jin Sun Lee
- Myung Sun Lee
- Eun Young Cha
- Phuong Thien Thuong
- Ji Young Sul
- Jun Beom Park
- Young Bok Ko
View Affiliations

Affiliations: Department of Surgery and Research Institute for Medicinal Sciences, Chungnam National University College of Medicine, Daejeon 35015, Republic of Korea, Surgical Oncology Research Lab, Chungnam National University Hospital, Daejeon 35015, Republic of Korea, Department of Herbal Analysis and Standardization, National Institute of Medicinal Materials, Hanoi 100000, Vietnam, Department of Obstetrics and Gynecology and Research Institute for Medicinal Sciences, Chungnam National University College of Medicine, Daejeon 35015, Republic of Korea
Published online on: August 9, 2018 https://doi.org/10.3892/mmr.2018.9377
Pages: 3898-3906
Copyright: © Lee et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Ovarian cancer is one of the most common causes of female mortalities from gynecological tumors. An ent‑kaurane diterpenoid compound CRT1 (ent‑18‑acetoxy‑7β‑hydroxy kaur‑15‑oxo‑16‑ene), mainly isolated from the Vietnamese herb Croton tonkinesis has been used in folk medicine in Vietnam for cancer treatment. However, the effect of this compound on human ovarian cancer cells has not yet been reported. The objective of the present study was to determine the effect of CRT1 on the cell viability, apoptosis and metastasis of SKOV3 human ovarian cancer cells using a Cell Counting Kit‑8 assay, flow cytometric analysis of Annexin V‑fluorescein isothiocyanate/propidium iodide staining, western blot analysis, soft agar colony forming assay, wound healing assay and Matrigel invasion assay. The results revealed that CRT1 possessed significant anti‑proliferative effects on SKOV3 cells. CRT1 treatment at 25 and 50 µM induced apoptosis, enhanced the percentage of Annexin V‑positive cells, increased the expression of pro‑apoptotic protein B‑cell lymphoma 2 (Bcl‑2)‑associated X protein, cytochrome c release from the mitochondria to the cytosol, cleaved caspase‑3, caspase‑7, caspase‑9, and poly (adenosine diphosphate‑ribose) polymerase. However, it decreased the expression of Bcl‑2 in a dose‑dependent manner. The percentage of necrotic cells increased following CRT1 treatment at <10 µM. CRT1 at 50 µM significantly induced the phosphorylation of extracellular signal‑regulated kinase (ERK). Growth inhibition and the apoptotic effects of CRT1 could be reversed by PD98059, an ERK inhibitor. Additionally, CRT1 inhibited cell migration and invasion via ERK1/2 activation in SKOV3 cells. These results indicated that CRT1, an ent‑kaurane diterpenoid, may be a potential inhibitor of ovarian cancer by the activating ERK1/2/p90 ribosomal S6 kinase signaling pathway.

View Figures

View References

1	Serkies K, Węgrzynowicz E and Jassem J: Paclitaxel and cisplatin chemotherapy for ovarian cancer during pregnancy: Case report and review of the literature. Arch Gynecol Obstet. 283 Suppl 1:S97–S100. 2011. View Article : Google Scholar
2	Wen W, Wu J, Liu L, Tian Y, Buettner R, Hsieh MY, Horne D, Dellinger TH, Han ES, Jove R and Yim JH: Synergistic anti-tumor effect of combined inhibition of EGFR and JAK/STAT3 pathways in human ovarian cancer. Mol Cancer. 14:1002015. View Article : Google Scholar : PubMed/NCBI
3	Vaughan S, Coward JI, Bast RC Jr, Berchuck A, Berek JS, Brenton JD, Coukos G, Crum CC, Drapkin R, Etemadmoghadam D, et al: Rethinking ovarian cancer: Recommendations for improving outcomes. Nat Rev Cancer. 11:719–725. 2011. View Article : Google Scholar : PubMed/NCBI
4	Lu Z and Xu S: ERK1/2 MAP kinases in cell survival and apoptosis. IUBMB Life. 58:621–631. 2006. View Article : Google Scholar : PubMed/NCBI
5	Cagnol S and Chambard JC: ERK and cell death: Mechanisms of ERK-induced cell death-apoptosis, autophagy and senescence. FEBS J. 277:2–21. 2010. View Article : Google Scholar : PubMed/NCBI
6	Calvo N, Carriere P, Martin MJ and Gentili C: RSK activation via ERK modulates human colon cancer cells response to PTHrP. J Mol Endocrinol. 59:13–27. 2017. View Article : Google Scholar : PubMed/NCBI
7	Giang PM, Son PT, Lee JJ and Otsuka H: Four ent-kaurane-type diterpenoids from Croton tonkinensis Gagnep. Chem Pharm Bull (Tokyo). 52:879–882. 2004. View Article : Google Scholar : PubMed/NCBI
8	Do TL: Medicinal plants and remedies of Vietnam. Publishing House Medicine; Hanoi: pp. 826–828. 2001
9	Kuo PC, Shen YC, Yang ML, Wang SH, Thang TD, Dung NX, Chiang PC, Lee KH, Lee EJ and Wu TS: Crotonkinins A and B and related diterpenoids from Croton tonkinensis as anti-inflammatory and antitumor agents. J Nat Prod. 70:1906–1909. 2007. View Article : Google Scholar : PubMed/NCBI
10	Phan MG, Phan TS, Hamada Y and Otsuka H: Cytotoxic diterpenoids from Vietnamese medicinal plant Croton tonkinensis GAGNEP. Chem Pharm Bull (Tokyo). 53:296–300. 2005. View Article : Google Scholar : PubMed/NCBI
11	Thuong PT, Khoi NM, Ohta S, Shiota S, Kanta H, Takeuchi K and Ito F: ent-kaurane diterpenoids from Croton tonkinensis induce apoptosis in colorectal cancer cells through the phosphorylation of JNK mediated by reactive oxygen species and dual-specificity JNK kinase MKK4. Anticancer Agents Med Chem. 14:1051–1061. 2014. View Article : Google Scholar : PubMed/NCBI
12	Giang PM, Jin HZ, Son PT, Lee JH, Hong YS and Lee JJ: ent-Kaurane diterpenoids from croton tonkinensis inhibit LPS-induced NF-kappaB activation and NO production. J Nat Prod. 66:1217–1220. 2003. View Article : Google Scholar : PubMed/NCBI
13	Thuong PT, Dao TT, Pham TH, Nguyen PH, Le TV, Lee KY and Oh WK: Crotonkinensins A and B, diterpenoids from the Vietnamese medicinal plant Croton tonkinensis. J Nat Prod. 72:1–2042. 2009. View Article : Google Scholar
14	Dao TT, Le TV, Nguyen PH, Thuong PT, Minh PT, Woo ER, Lee KY and Oh WK: SIRT1 inhibitory diterpenoids from the Vietnamese medicinal plant Croton tonkinensis. Planta Med. 76:1011–1014. 2010. View Article : Google Scholar : PubMed/NCBI
15	Dao TT, Lee KY, Jeong HM, Nguyen PH, Tran TL, Thuong PT, Nguyen BT and Oh WK: ent-Kaurane diterpenoids from Croton tonkinensis stimulate osteoblast differentiation. J Nat Prod. 74:2526–2531. 2011. View Article : Google Scholar : PubMed/NCBI
16	Lu J, Chen X, Qu S, Yao B, Xu Y, Wu J, Jin Y and Ma C: Oridonin induces G₂/M cell cycle arrest and apoptosis via the PI3K/Akt signaling pathway in hormone-independent prostate cancer cells. Oncol Lett. 13:2838–2846. 2017. View Article : Google Scholar : PubMed/NCBI
17	Deng R, Tang J, Xia LP, Li DD, Zhou WJ, Wang LL, Feng GK, Zeng YX, Gao YH and Zhu XF: ExcisaninA, a diterpenoid compound purified from Isodon MacrocalyxinD, induces tumor cells apoptosis and suppresses tumor growth through inhibition of PKB/AKT kinase activity and blockade of its signal pathway. Mol Cancer Ther. 8:873–882. 2009. View Article : Google Scholar : PubMed/NCBI
18	Sul YH, Lee MS, Cha EY, Thuong PT, Khoi NM and Song IS: An ent-kaurane diterpenoid from Croton tonkinensis induces apoptosis by regulating AMP-activated protein kinase in SK-HEP1 human hepatocellular carcinoma cells. Biol Pharm Bull. 36:158–164. 2013. View Article : Google Scholar : PubMed/NCBI
19	Ye Q, Yao G, Zhang M, Guo G, Hu Y, Jiang J, Cheng L, Shi J, Li H, Zhang Y and Liu H: A novel ent-kaurane diterpenoid executes antitumor function in colorectal cancer cells by inhibiting Wnt/β-catenin signaling. Carcinogenesis. 36:318–326. 2015. View Article : Google Scholar : PubMed/NCBI
20	Zhou X, Yue GG, Chan AM, Tsui SK, Fung KP, Sun H, Pu J and Lau CB: Eriocalyxin B, a novel autophagy inducer, exerts anti-tumor activity through the suppression of Akt/mTOR/p70S6K signaling pathway in breast cancer. Biochem Pharmacol. 142:58–70. 2017. View Article : Google Scholar : PubMed/NCBI
21	Chipuk JE, Kuwana T, Bouchier-Hayes L, Droin NM, Newmeyer DD, Schuler M and Green DR: Direct activation of Bax by p53 mediates mitochondrial membrane permeabilization and apoptosis. Science. 303:1010–1014. 2004. View Article : Google Scholar : PubMed/NCBI
22	Xia R, Chen SX, Qin Q, Chen Y, Zhang WW, Zhu RR and Deng AM: Oridonin suppresses proliferation of human ovarian cancer cells via blockage of mTOR signaling. Asian Pac J Cancer Prev. 17:667–671. 2016. View Article : Google Scholar : PubMed/NCBI
23	Qiu S, Wu X, Liao H, Zeng X, Zhang S, Lu X, He X, Zhang X, Ye W, Wu H and Zhu X: Pteisolic acid G, a novel ent-kaurane diterpenoid, inhibits viability and induces apoptosis in human colorectal carcinoma cells. Oncol Lett. 14:5540–5548. 2017.PubMed/NCBI
24	Li L, Yue GG, Lau CB, Sun H, Fung KP, Leung PC, Han Q and Leung PS: Eriocalyxin B induces apoptosis and cell cycle arrest in pancreatic adenocarcinoma cells through caspase- and p53-dependent pathways. Toxicol Appl Pharmacol. 262:80–90. 2012. View Article : Google Scholar : PubMed/NCBI
25	Yao R, Chen Z, Zhou C, Luo M, Shi X, Li J, Gao Y, Zhou F, Pu J, Sun H and He J: Xerophilusin B induces cell cycle arrest and apoptosis in esophageal squamous cell carcinoma cells and does not cause toxicity in nude mice. J Nat Prod. 78:10–16. 2015. View Article : Google Scholar : PubMed/NCBI
26	Liao YJ, Bai HY, Li ZH, Zou J, Chen JW, Zheng F, Zhang JX, Mai SJ, Zeng MS, Sun HD, et al: Longikaurin A, a natural ent-kaurane, induces G2/M phase arrest via downregulation of Skp2 and apoptosis induction through ROS/JNK/c-Jun pathway in hepatocellular carcinoma cells. Cell Death Dis. 5:e11372014. View Article : Google Scholar : PubMed/NCBI
27	Liu JJ, Huang RW, Lin DJ, Wu XY, Peng J, Pan XL, Lin Q, Hou M, Zhang MH and Chen F: Antiproliferation effects of oridonin on HPB-ALL cells and its mechanisms of action. Am J Hematol. 81:86–94. 2006. View Article : Google Scholar : PubMed/NCBI
28	Liu GA, Chang JC, Feng XL and Ding L: Apoptosis induced by weisiensin B isolated from Rabdosia weisiensis C.Y. Wu in K562. Pharmazie. 70:263–268. 2015.PubMed/NCBI
29	Miller CR, Oliver KE and Farley JH: MEK1/2 inhibitors in the treatment of gynecologic malignancies. Gynecol Oncol. 133:128–137. 2014. View Article : Google Scholar : PubMed/NCBI
30	Torchiaro E, Lorenzato A, Olivero M, Valdembri D, Gagliardi PA, Gai M, Erriquez J, Serini G and Di Renzo MF: Peritoneal and hematogenous metastases of ovarian cancer cells are both controlled by the p90RSK through a self-reinforcing cell autonomous mechanism. Oncotarget. 7:712–728. 2016. View Article : Google Scholar : PubMed/NCBI
31	Kim JH, Jeong SJ, Kim B, Yun SM, Choi DY and Kim SH: Melatonin synergistically enhances cisplatin-induced apoptosis via the dephosphorylation of ERK/p90 ribosomal S6 kinase/heat shock protein 27 in SK-OV-3 cells. J Pineal Res. 52:244–252. 2012. View Article : Google Scholar : PubMed/NCBI
32	Bai RX, Wang WP, Zhao PW and Li CB: Ghrelin attenuates the growth of HO-8910 ovarian cancer cells through the ERK pathway. Braz J Med Biol Res. 49(pii): S0100879×2016000300602. 2016.
33	Kuo LM, Kuo CY, Lin CY, Hung MF, Shen JJ and Hwang TL: Intracellular glutathione depletion by oridonin leads to apoptosis in hepatic stellate cells. Molecules. 19:3327–3344. 2014. View Article : Google Scholar : PubMed/NCBI
34	Tanimura S and Takeda K: ERK signalling as a regulator of cell motility. J Biochem. 162:145–154. 2017. View Article : Google Scholar : PubMed/NCBI
35	Kaur G and Dufour JM: Cell lines: Valuable tools or useless artifacts. Spermatogenesis. 2:1–5. 2012. View Article : Google Scholar : PubMed/NCBI